MicroRNA Market

Global MicroRNA Market Size, Trends & Analysis - Forecasts to 2028 By Products & Services (Instruments, Consumables, and Services), Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, and Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Others), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 16 2024 with the latest and most recent market numbers

Global MicroRNA Market Size

The global microRNA market is expected to grow at a CAGR of 12.64 % from 2023 to 2028. The global microRNA market is experiencing steady growth and showing promising potential. MicroRNAs are small, non-coding RNA molecules crucial in regulating gene expression. These are increasingly studied for their diagnostic and therapeutic applications in various diseases, including cancer, cardiovascular diseases, neurological disorders, and more. The advent of ground-breaking innovations like CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and NGS (Next-Generation Sequencing) has significantly impacted the fields of biotechnology, genomics, and healthcare. These technological advancements have revolutionized scientific research and opened up new possibilities for therapeutic developments and diagnostics.

One area where these innovations have played a crucial role is in microRNA (miRNA) therapeutics. MicroRNAs are short RNA molecules that regulate gene expression, and they have emerged as promising candidates for therapeutic interventions. With the help of CRISPR and NGS technologies, researchers have better understood the functions of microRNA and their roles in various diseases. This deeper understanding has accelerated clinical trials focused on microRNA-based therapies. Scientists have been exploring the role of microRNA in the context of the SARS-CoV-2 virus and COVID-19 disease. They have been investigating how microRNA can modulate gene expression in response to the virus and how they might be potential targets for therapeutic interventions. Additionally, microRNA research has contributed to developing COVID-19 vaccines, as understanding the molecular pathways regulated by microRNA has provided valuable insights for vaccine design and development.

The combination of CRISPR, NGS, and the focus on microRNA research due to the COVID-19 pandemic has accelerated progress in both genomics and the healthcare sector. These innovations have opened up new avenues for therapeutic development, expanded the understanding of disease mechanisms, and advanced the field of personalized medicine. Research in these fields has the potential to revolutionize treatment forever and lead to better patient outcomes.

global microrna market

Global MicroRNA Market: By Products & Services

Based on product & service, the market is segmented into instruments, consumables, and services. The service segment is expected to be the largest segment during the forecast period. This is due to microRNA research often requiring specialized expertise and access to advanced technologies. Many research institutions and pharmaceutical companies prefer to outsource specific microRNA-related tasks to specialized service providers with the necessary knowledge. The increasing interest in microRNA research for both basic research and therapeutic applications has led to a higher demand for microRNA-related services, leading to their dominance in the market.

Global MicroRNA Market: By Application

Based on application, the market is segmented into cancer, infectious diseases, immunological disorder, cardiovascular disease neurological disease, others. The cancer segment is anticipated to be the largest segment during the forecast period. This is because, in cancer research, microRNAs play a crucial role as they are involved in regulating the expression of genes associated with tumor growth, metastasis, and drug resistance. They can act as oncogenes, promoting cancer development or tumor suppressors, inhibiting cancer progression. Understanding the dysregulation of microRNA in cancer has opened up new avenues for cancer diagnosis, prognosis, and targeted therapies. The global cancer burden has been rising, with cancer being one of the leading causes of death worldwide. The need for effective cancer diagnosis and treatment has fueled research into microRNA biomarkers and therapeutics.

Global MicroRNA Market: By End User

Based on end user, the market is segmented into biotechnology & pharmaceutical companies and academic & government research institutes. The academic & government research institutes segment is expected to be the largest segment during the forecast period. The growth is attributed to academic and government research institutes playing a critical role in advancing microRNA research and understanding its implications across diverse fields, including molecular biology, genetics, and disease mechanisms. These organisations are focal points for basic investigation into the functions of microRNA in numerous biological processes and illnesses. Access to cutting-edge technologies, such as next-generation sequencing (NGS) and advanced bioinformatics tools, has revolutionized microRNA research. Academic and government research institutes often have access to these technologies, enabling comprehensive microRNA profiling and functional studies, making the academic & government research institutes segment the largest in the market.

asia pacific microrna market

Global MicroRNA Market: By Region

North America is analyzed to be the largest region in the global microRNA market during the forecast period. Comprising the United States, Canada, and Mexico, North America features a robust scientific landscape with prominent research and academic institutions that strongly focus on life sciences and biotechnology. These institutions aids in micoRNA research, leading to ground breaking discoveries and advancements in understanding micoRNA functions and their implications in various diseases. The excellent healthcare system in the region also helps the micoRNA market to expand. With top-tier medical centers and pharmaceutical companies, North America possesses the necessary resources and expertise to translate micoRNA research findings into practical clinical applications. This enables efficient testing, validation, and commercialization of micoRNA biomarkers and therapeutics, driving the adoption of micoRNA -based solutions in the region, and key industry players make it the largest segment in the global microRNA market.

Asia Pacific is also analyzed to be the fastest growing region in the global microRNA market. One major factor for the growth of the micoRNA market in the Asia Pacific is the substantial investment in research and development by both governments and private institutions. The region's increasing focus on the life sciences, biotechnology, and healthcare sectors has led to notable advancements in micoRNA research. This heightened interest and investment are fostering an environment conducive to the growth of the micoRNA market. Asia Pacific’s increasing interest in precision medicine micoRNAs offer immense potential for personalized treatments and targeted therapies, aligning with the region's precision medicine objectives. This increased focus on precision medicine is fuelling the demand for micoRNA-based diagnostics and therapeutics in the Asia Pacific region. These factors contribute to the region's position as a major market for companies operating in the global microRNA market.

Global MicroRNA Market Share and Competitor Analysis

The key players operating in the market are Merck KGaA, Thermo Fisher Scientific, Inc., Horizon Discovery Ltd., Synlogic, QIAGEN, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString, and BioGenex, among others.

Please note: This is not an exhaustive list of companies profiled in the report.

1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS

1.1 Strategic Opportunity & Attractiveness Analysis

1.1.1 Hot Revenue Pockets

1.1.2 Market Attractiveness Score

1.1.3 Revenue Impacting Opportunity

1.1.4 High Growing Region/Country

1.1.5 Competitor Analysis

1.1.6 Consumer Analysis

1.2 Global Market Estimates' View

1.3 Strategic Insights across Business Functions

1.3.1 For Chief Executive Officers

1.3.2 For Chief Marketing Officers

1.3.3 For Chief Strategy Officers

1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into

2 TECHNOLOGICAL TRENDS

2.1 Technological Adoption Rate

2.2 Current Trend Impact Analysis

2.3 Future Trend Impact Analysis

2.4 Data Metrics

3 GLOBAL MICRORNA MARKET OUTLOOK

3.1 Market Pyramid Analysis

3.1.1 Introduction

3.1.2 Adjacent Market Opportunities

3.1.3 Ancillary Market Opportunities

3.2 Demand Side Analysis

3.2.1 Market Drivers: Impact Analysis

3.2.2 Market Restraints: Impact Analysis

3.2.3 Market Opportunities: Impact Analysis

3.2.4 Market Challenges: Impact Analysis

3.3 Supply Side Analysis

3.3.1 Porter’s Five Forces Analysis

3.3.1.1 Threat of New Entrants

3.3.1.2 Threat of New Substitutes

3.3.1.3 Bargaining Power of Suppliers

3.3.1.4 Bargaining Power of Buyers

3.3.1.5 Intensity of Competitive Rivalry

3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)

3.3.2.1 Political Landscape

3.3.2.2 Economic Landscape

3.3.2.3 Social Landscape

3.3.2.4 Technology Landscape

3.3.3 Value Chain Analysis

3.3.4 Trend Analysis

3.3.5 Gap Analysis

3.3.6 Cost Analysis

4 GLOBAL MICRORNA MARKET, BY PRODUCTS & SERVICES

4.1 Introduction

4.2 MicroRNA Market: Products & Services Scope Key Takeaways

4.3 Revenue Growth Analysis, 2022 & 2028

4.4 Instruments

4.4.1 Instruments Market Estimates and Forecast, 2020-2028 (USD Million)

4.5 Consumables

4.5.1 Consumables Market Estimates and Forecast, 2020-2028 (USD Million)

4.6 Services

4.6.1 Services Market Estimates and Forecast, 2020-2028 (USD Million)

5 GLOBAL MICRORNA MARKET, BY END USE

5.1 Introduction

5.2 MicroRNA Market: End Use Scope Key Takeaways

5.3 Revenue Growth Analysis, 2022 & 2028

5.4 Biotechnology & Pharmaceutical Companies

5.4.1 Biotechnology & Pharmaceutical Companies Market Estimates and Forecast, 2020-2028 (USD Million)

5.5 Academic & Government Research Institutes

5.5.1 Academic & Government Research Institutes Market Estimates and Forecast, 2020-2028 (USD Million)

5.5 Others

5.5.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)

6 GLOBAL MICRORNA MARKET, BY APPLICATION

6.1 Introduction

6.2 MicroRNA Market: Application Scope Key Takeaways

6.3 Revenue Growth Analysis, 2022 & 2028

6.4 Cancer

6.4.1 Cancer Market Estimates and Forecast, 2020-2028 (USD Million)

6.5 Infectious Diseases

6.5.1 Infectious Diseases Market Estimates and Forecast, 2020-2028 (USD Million)

6.6 Immunological Disorder

6.6.1 Immunological Disorder Market Estimates and Forecast, 2020-2028 (USD Million)

6.7 Cardiovascular Disease

6.7.1 Cardiovascular Disease Market Estimates and Forecast, 2020-2028 (USD Million)

6.8 Cardiovascular Disease

6.8.1 Cardiovascular Disease Market Estimates and Forecast, 2020-2028 (USD Million)

6.9 Neurological Disease

6.9.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)

7 GLOBAL MICRORNA MARKET, BY REGION

7.1 Introduction

7.2 North America MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.1 By Products & Services

7.2.2 By End Use

7.2.3 By Application

7.2.4 By Country

7.2.4.1 U.S. MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.1.1 By Products & Services

7.2.4.1.2 By End Use

7.2.4.1.3 By Application

7.2.4.2 Canada MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.2.1 By Products & Services

7.2.4.2.2 By End Use

7.2.4.2.3 By Application

7.2.4.3 Mexico MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.3.1 By Products & Services

7.2.4.3.2 By End Use

7.2.4.3.3 By Application

7.3 Europe MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.1 By Products & Services

7.3.2 By End Use

7.3.3 By Application

7.3.4 By Country

7.3.4.1 Germany MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.1.1 By Products & Services

7.3.4.1.2 By End Use

7.3.4.1.3 By Application

7.3.4.2 U.K. MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.2.1 By Products & Services

7.3.4.2.2 By End Use

7.3.4.2.3 By Application

7.3.4.3 France MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.3.1 By Products & Services

7.3.4.3.2 By End Use

7.3.4.3.3 By Application

7.3.4.4 Italy MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.4.1 By Products & Services

7.3.4.4.2 By End Use

7.2.4.4.3 By Application

7.3.4.5 Spain MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.5.1 By Products & Services

7.3.4.5.2 By End Use

7.2.4.5.3 By Application

7.3.4.6 Netherlands MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.6.1 By Products & Services

7.3.4.6.2 By End Use

7.2.4.6.3 By Application

7.3.4.7 Rest of Europe MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.7.1 By Products & Services

7.3.4.7.2 By End Use

7.2.4.7.3 By Application

7.4 Asia Pacific MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.1 By Products & Services

7.4.2 By End Use

7.4.3 By Application

7.4.4 By Country

7.4.4.1 China MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.1.1 By Products & Services

7.4.4.1.2 By End Use

7.4.4.1.3 By Application

7.4.4.2 Japan MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.2.1 By Products & Services

7.4.4.2.2 By End Use

7.4.4.2.3 By Application

7.4.4.3 India MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.3.1 By Products & Services

7.4.4.3.2 By End Use

7.4.4.3.3 By Application

7.4.4.4 South Korea MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.4.1 By Products & Services

7.4.4.4.2 By End Use

7.4.4.4.3 By Application

7.4.4.5 Singapore MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.5.1 By Products & Services

7.4.4.5.2 By End Use

7.4.4.5.3 By Application

7.4.4.6 Malaysia MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.6.1 By Products & Services

7.4.4.6.2 By End Use

7.4.4.6.3 By Application

7.4.4.7 Thailand MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.7.1 By Products & Services

7.4.4.7.2 By End Use

7.4.4.7.3 By Application

7.4.4.8 Indonesia MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.8.1 By Products & Services

7.4.4.8.2 By End Use

7.4.4.8.3 By Application

7.4.4.9 Vietnam MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.9.1 By Products & Services

7.4.4.9.2 By End Use

7.4.4.9.3 By Application

7.4.4.10 Taiwan MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.10.1 By Products & Services

7.4.4.10.2 By End Use

7.4.4.10.3 By Application

7.4.4.11 Rest of Asia Pacific MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.11.1 By Products & Services

7.4.4.11.2 By End Use

7.4.4.11.3 By Application

7.5 Middle East and Africa MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.1 By Products & Services

7.5.2 By End Use

7.5.3 By Application

7.5.4 By Country

7.5.4.1 Saudi Arabia MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.1.1 By Products & Services

7.5.4.1.2 By End Use

7.5.4.1.3 By Application

7.5.4.2 U.A.E. MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.2.1 By Products & Services

7.5.4.2.2 By End Use

7.5.4.2.3 By Application

7.5.4.3 Israel MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.3.1 By Products & Services

7.5.4.3.2 By End Use

7.5.4.3.3 By Application

7.5.4.4 South Africa MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.4.1 By Products & Services

7.5.4.4.2 By End Use

7.5.4.4.3 By Application

7.5.4.5 Rest of Middle East and Africa MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.5.1 By Products & Services

7.5.4.5.2 By End Use

7.5.4.5.2 By Application

7.6 Central & South America MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.1 By Products & Services

7.6.2 By End Use

7.6.3 By Application

7.6.4 By Country

7.6.4.1 Brazil MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.1.1 By Products & Services

7.6.4.1.2 By End Use

7.6.4.1.3 By Application

7.6.4.2 Argentina MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.2.1 By Products & Services

7.6.4.2.2 By End Use

7.6.4.2.3 By Application

7.6.4.3 Chile MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.3.1 By Products & Services

7.6.4.3.2 By End Use

7.6.4.3.3 By Application

7.6.4.4 Rest of Central & South America MicroRNA Market Estimates and Forecast, 2020-2028 (USD Million)

7.6.4.4.1 By Products & Services

7.6.4.4.2 By End Use

7.6.4.4.3 By Application

8 COMPETITIVE LANDCAPE

8.1 Company Market Share Analysis

8.2 Four Quadrant Positioning Matrix

8.2.1 Market Leaders

8.2.2 Market Visionaries

8.2.3 Market Challengers

8.2.4 Niche Market Players

8.3.4 Rest of the World

8.4 Company Profiles

8.4.1 Merck KGaA

8.4.1.1 Business Description & Financial Analysis

8.4.1.2 SWOT Analysis

8.4.1.3 Products & Services Offered

8.4.1.4 Strategic Alliances between Business Partners

8.4.2 Thermo Fisher Scientific, Inc.

8.4.2.1 Business Description & Financial Analysis

8.4.2.2 SWOT Analysis

8.4.2.3 Products & Services Offered

8.4.2.4 Strategic Alliances between Business Partners

8.4.3 Horizon Discovery Ltd.

8.4.3.1 Business Description & Financial Analysis

8.4.3.2 SWOT Analysis

8.4.3.3 Products & Services Offered

8.4.3.4 Strategic Alliances between Business Partners

8.4.4 Synlogic

8.4.4.1 Business Description & Financial Analysis

8.4.4.2 SWOT Analysis

8.4.4.3 Products & Services Offered

8.4.4.4 Strategic Alliances between Business Partners

8.4.5 QIAGEN

8.4.5.1 Business Description & Financial Analysis

8.4.5.2 SWOT Analysis

8.4.5.3 Products & Services Offered

8.4.5.4 Strategic Alliances between Business Partners

8.4.6 GENECOPOEIA, INC.

8.4.6.1 Business Description & Financial Analysis

8.4.6.2 SWOT Analysis

8.4.6.3 Products & Services Offered

8.4.6.4 Strategic Alliances between Business Partners

8.4.7 New England Biolabs

8.4.7.1 Business Description & Financial Analysis

8.4.7.2 SWOT Analysis

8.4.7.3 Products & Services Offered

8.4.8.4 Strategic Alliances between Business Partners

8.4.8 Quantabio

8.4.8.1 Business Description & Financial Analysis

8.4.8.2 SWOT Analysis

8.4.8.3 Products & Services Offered

8.4.8.4 Strategic Alliances between Business Partners

8.4.9 NanoString

8.4.9.1 Business Description & Financial Analysis

8.4.9.2 SWOT Analysis

8.4.9.3 Products & Services Offered

8.4.9.4 Strategic Alliances between Business Partners

8.4.10 BioGenex

8.4.10.1 Business Description & Financial Analysis

8.4.10.2 SWOT Analysis

8.4.10.3 Products & Services Offered

8.4.10.4 Strategic Alliances between Business Partners

8.4.11 Other Companies

8.4.11.1 Business Description & Financial Analysis

8.4.11.2 SWOT Analysis

8.4.11.3 Products & Services Offered

8.4.11.4 Strategic Alliances between Business Partners

9 RESEARCH METHODOLOGY

9.1 Market Introduction

9.1.1 Market Definition

9.1.2 Market Scope & Segmentation

9.2 Information Procurement

9.2.1 Secondary Research

9.2.1.1 Purchased Databases

9.2.1.2 GMEs Internal Data Repository

9.2.1.3 Secondary Resources & Third Party Perspectives

9.2.1.4 Company Information Sources

9.2.2 Primary Research

9.2.2.1 Various Types of Respondents for Primary Interviews

9.2.2.2 Number of Interviews Conducted throughout the Research Process

9.2.2.3 Primary Stakeholders

9.2.2.4 Discussion Guide for Primary Participants

9.2.3 Expert Panels

9.2.3.1 Expert Panels Across 30+ Industry

9.2.4 Paid Local Experts

9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region

9.3 Market Estimation

9.3.1 Top-Down Approach

9.3.1.1 Macro-Economic Indicators Considered

9.3.1.2 Micro-Economic Indicators Considered

9.3.2 Bottom Up Approach

9.3.2.1 Company Share Analysis Approach

9.3.2.2 Estimation of Potential Product Sales

9.4 Data Triangulation

9.4.1 Data Collection

9.4.2 Time Series, Cross Sectional & Panel Data Analysis

9.4.3 Cluster Analysis

9.5 Analysis and Output

9.5.1 Inhouse AI Based Real Time Analytics Tool

9.5.2 Output From Desk & Primary Research

9.6 Research Assumptions & Limitations

9.7.1 Research Assumptions

9.7.2 Research Limitations

LIST OF TABLES

1 Global MicroRNA Market, By Products & Services, 2020-2028 (USD Mllion)

2 Instruments Market, By Region, 2020-2028 (USD Mllion)

3 Consumables Market, By Region, 2020-2028 (USD Mllion)

4 Services Market, By Region, 2020-2028 (USD Mllion)

5 Global MicroRNA Market, By End Use, 2020-2028 (USD Mllion)

6 Biotechnology & Pharmaceutical Companies Market, By Region, 2020-2028 (USD Mllion)

7 Academic & Government Research Institutes Market, By Region, 2020-2028 (USD Mllion)

8 Others Research Institutes Market, By Region, 2020-2028 (USD Mllion)

9 Global MicroRNA Market, By Application, 2020-2028 (USD Mllion)

10 Cancer Market, By Region, 2020-2028 (USD Mllion)

11 Infectious Diseases Market, By Region, 2020-2028 (USD Mllion)

12 Immunological Disorder Market, By Region, 2020-2028 (USD Mllion)

13 Cardiovascular Disease Market, By Region, 2020-2028 (USD Mllion)

14 Neurological Disease Market, By Region, 2020-2028 (USD Mllion)

15 Others Market, By Region, 2020-2028 (USD Mllion)

16 Regional Analysis, 2020-2028 (USD Mllion)

17 North America MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

18 North America MicroRNA Market, By End Use, 2020-2028 (USD Million)

19 North America MicroRNA Market, By Application, 2020-2028 (USD Million)

20 North America MicroRNA Market, By Country, 2020-2028 (USD Million)

21 U.S MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

22 U.S MicroRNA Market, By End Use, 2020-2028 (USD Million)

23 U.S MicroRNA Market, By Application, 2020-2028 (USD Million)

24 Canada MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

25 Canada MicroRNA Market, By End Use, 2020-2028 (USD Million)

26 Canada MicroRNA Market, By Application, 2020-2028 (USD Million)

27 Mexico MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

28 Mexico MicroRNA Market, By End Use, 2020-2028 (USD Million)

29 Mexico MicroRNA Market, By Application, 2020-2028 (USD Million)

30 Europe MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

31 Europe MicroRNA Market, By End Use, 2020-2028 (USD Million)

32 Europe MicroRNA Market, By Application, 2020-2028 (USD Million)

33 Germany MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

34 Germany MicroRNA Market, By End Use, 2020-2028 (USD Million)

35 Germany MicroRNA Market, By Application, 2020-2028 (USD Million)

36 UK MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

37 UK MicroRNA Market, By End Use, 2020-2028 (USD Million)

38 UK MicroRNA Market, By Application, 2020-2028 (USD Million)

39 France MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

40 France MicroRNA Market, By End Use, 2020-2028 (USD Million)

41 France MicroRNA Market, By Application, 2020-2028 (USD Million)

42 Italy MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

43 Italy MicroRNA Market, By T End Use Type, 2020-2028 (USD Million)

44 Italy MicroRNA Market, By Application, 2020-2028 (USD Million)

45 Spain MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

46 Spain MicroRNA Market, By End Use, 2020-2028 (USD Million)

47 Spain MicroRNA Market, By Application, 2020-2028 (USD Million)

48 Rest Of Europe MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

49 Rest Of Europe MicroRNA Market, By End Use, 2020-2028 (USD Million)

50 Rest of Europe MicroRNA Market, By Application, 2020-2028 (USD Million)

51 Asia Pacific MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

52 Asia Pacific MicroRNA Market, By End Use, 2020-2028 (USD Million)

53 Asia Pacific MicroRNA Market, By Application, 2020-2028 (USD Million)

54 Asia Pacific MicroRNA Market, By Country, 2020-2028 (USD Million)

55 China MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

56 China MicroRNA Market, By End Use, 2020-2028 (USD Million)

57 China MicroRNA Market, By Application, 2020-2028 (USD Million)

58 India MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

59 India MicroRNA Market, By End Use, 2020-2028 (USD Million)

60 India MicroRNA Market, By Application, 2020-2028 (USD Million)

61 Japan MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

62 Japan MicroRNA Market, By End Use, 2020-2028 (USD Million)

63 Japan MicroRNA Market, By Application, 2020-2028 (USD Million)

64 South Korea MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

65 South Korea MicroRNA Market, By End Use, 2020-2028 (USD Million)

66 South Korea MicroRNA Market, By Application, 2020-2028 (USD Million)

67 Middle East and Africa MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

68 Middle East and Africa MicroRNA Market, By End Use, 2020-2028 (USD Million)

69 Middle East and Africa MicroRNA Market, By Application, 2020-2028 (USD Million)

70 Middle East and Africa MicroRNA Market, By Country, 2020-2028 (USD Million)

71 Saudi Arabia MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

72 Saudi Arabia MicroRNA Market, By End Use, 2020-2028 (USD Million)

73 Saudi Arabia MicroRNA Market, By Application, 2020-2028 (USD Million)

74 UAE MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

75 UAE MicroRNA Market, By End Use, 2020-2028 (USD Million)

76 UAE MicroRNA Market, By Application, 2020-2028 (USD Million)

77 Central & South America MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

78 Central & South America MicroRNA Market, By End Use, 2020-2028 (USD Million)

79 Central & South America MicroRNA Market, By Application, 2020-2028 (USD Million)

80 Central & South America MicroRNA Market, By Country, 2020-2028 (USD Million)

81 Brazil MicroRNA Market, By Products & Services, 2020-2028 (USD Million)

82 Brazil MicroRNA Market, By End Use, 2020-2028 (USD Million)

83 Brazil MicroRNA Market, By Application, 2020-2028 (USD Million)

84 Merck KGaA: Products & Services Offering

85 Thermo Fisher Scientific, Inc.: Products & Services Offering

86 Horizon Discovery Ltd.: Products & Services Offering

87 Synlogic: Products & Services Offering

88 QIAGEN: Products & Services Offering

89 GENECOPOEIA, INC.: Products & Services Offering

90 New England Biolabs : Products & Services Offering

91 Quantabio: Products & Services Offering

92 NanoString, Inc: Products & Services Offering

93 BioGenex: Products & Services Offering

94 Other Companies: Products & Services Offering

LIST OF FIGURES

1 Global MicroRNA Market Overview

2 Global MicroRNA Market Value From 2020-2028 (USD Mllion)

3 Global MicroRNA Market Share, By Products & Services (2022)

4 Global MicroRNA Market Share, By End Use (2022)

5 Global MicroRNA Market Share, By Application (2022)

6 Global MicroRNA Market, By Region (Asia Pacific Market)

7 Technological Trends In Global MicroRNA Market

8 Four Quadrant Competitor Positioning Matrix

9 Impact Of Macro & Micro Indicators On The Market

10 Impact Of Key Drivers On The Global MicroRNA Market

11 Impact Of Challenges On The Global MicroRNA Market

12 Porter’s Five Forces Analysis

13 Global MicroRNA Market: By Products & Services Scope Key Takeaways

14 Global MicroRNA Market, By Products & Services Segment: Revenue Growth Analysis

15 Instruments Market, By Region, 2020-2028 (USD Mllion)

16 Consumables Market, By Region, 2020-2028 (USD Mllion)

17 Services Market, By Region, 2020-2028 (USD Mllion)

18 Global MicroRNA Market: By End Use Scope Key Takeaways

19 Global MicroRNA Market, By End Use Segment: Revenue Growth Analysis

20 Biotechnology & Pharmaceutical Companies Market, By Region, 2020-2028 (USD Mllion)

21 Academic & Government Research Institutes Market, By Region, 2020-2028 (USD Mllion)

22 Others Market, By Region, 2020-2028 (USD Mllion)

23 Global MicroRNA Market: By Application Scope Key Takeaways

24 Global MicroRNA Market, By Application Segment: Revenue Growth Analysis

25 Cancer Market, By Region, 2020-2028 (USD Mllion)

26 Infectious Diseases Market, By Region, 2020-2028 (USD Mllion)

27 Immunological Disorder Market, By Region, 2020-2028 (USD Mllion)

28 Cardiovascular Disease Market, By Region, 2020-2028 (USD Mllion)

29 Neurological Disease Market, By Region, 2020-2028 (USD Mllion)

30 Others Market, By Region, 2020-2028 (USD Mllion)

31 Regional Segment: Revenue Growth Analysis

32 Global MicroRNA Market: Regional Analysis

33 North America MicroRNA Market Overview

34 North America MicroRNA Market, By Products & Services

35 North America MicroRNA Market, By End Use

36 North America MicroRNA Market, By Application

37 North America MicroRNA Market, By Country

38 U.S. MicroRNA Market, By Products & Services

39 U.S. MicroRNA Market, By End Use

40 U.S. MicroRNA Market, By Application

41 Canada MicroRNA Market, By Products & Services

42 Canada MicroRNA Market, By End Use

43 Canada MicroRNA Market, By Application

44 Mexico MicroRNA Market, By Products & Services

45 Mexico MicroRNA Market, By End Use

46 Mexico MicroRNA Market, By Application

47 Four Quadrant Positioning Matrix

48 Company Market Share Analysis

49 Merck KGaA: Company Snapshot

50 Merck KGaA: SWOT Analysis

51 Merck KGaA: Geographic Presence

52 Thermo Fisher Scientific, Inc.: Company Snapshot

53 Thermo Fisher Scientific, Inc.: SWOT Analysis

54 Thermo Fisher Scientific, Inc.: Geographic Presence

55 Horizon Discovery Ltd.: Company Snapshot

56 Horizon Discovery Ltd.: SWOT Analysis

57 Horizon Discovery Ltd.: Geographic Presence

58 Synlogic: Company Snapshot

59 Synlogic: Swot Analysis

60 Synlogic: Geographic Presence

61 QIAGEN: Company Snapshot

62 QIAGEN: SWOT Analysis

63 QIAGEN: Geographic Presence

64 GENECOPOEIA, INC.: Company Snapshot

65 GENECOPOEIA, INC.: SWOT Analysis

66 GENECOPOEIA, INC.: Geographic Presence

67 New England Biolabs : Company Snapshot

68 New England Biolabs : SWOT Analysis

69 New England Biolabs : Geographic Presence

70 Quantabio: Company Snapshot

71 Quantabio: SWOT Analysis

72 Quantabio: Geographic Presence

73 NanoString, Inc.: Company Snapshot

74 NanoString, Inc.: SWOT Analysis

75 NanoString, Inc.: Geographic Presence

76 BioGenex: Company Snapshot

77 BioGenex: SWOT Analysis

78 BioGenex: Geographic Presence

79 Other Companies: Company Snapshot

80 Other Companies: SWOT Analysis

81 Other Companies: Geographic Presence

The Global MicroRNA Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the MicroRNA Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global microRNA market?

The global microRNA market is expected to grow at a CAGR of 12.64 % from 2023 to 2028.

Who are the major vendors in the global microRNA market?

What are the opportunities prevailing in the global microRNA market?

The global microRNA market is expected to gain opportunities due to therapeutic applications, technological advancements, expanding research collaborations, precision medicine, collaborations, and expansion into emerging markets. The development of microRNA-based therapies offers opportunities for innovative and targeted treatments that can address unmet medical needs.

What are the major drivers for the global microRNA market growth?

The global microRNA market growth is fuelled by increasing research and development activities, technological advancements, and rising prevalence of chronic diseases. Innovations like artificial intelligence and bioinformatics and microRNA biomarker discovery, is expected to drive the market growth.